Ute Hegenbart - Publications

Fat aspiration for amyloidosis screening of 2830 patients from 2013 to 2020: compelling sensitivity for AL and better sensitivity in females for all major subtypes.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: June 26, 2026

Determinants of Long-Term Benefit From High Dose Melphalan With Autologous Stem Cell Transplant in AL Amyloidosis.

Journal: American journal of hematology

Published: March 17, 2026

Amyloidosis: classification, diagnosis, and treatment

Journal: Innere Medizin (Heidelberg, Germany)

Published: March 01, 2026

Executive summary of the European consensus report on the diagnosis and treatment of monoclonal gammopathy of renal significance.

Journal: Clinical kidney journal

Published: January 28, 2026

Teclistamab in relapsed/refractory light chain amyloidosis: A retrospective multicenter study by the German Society for Amyloid Diseases.

Journal: HemaSphere

Published: January 20, 2026

Predicting Early Mortality in Newly Diagnosed AL Amyloidosis: Development and Validation of the PACE Score for Daratumumab-Treated Patients.

Journal: American journal of hematology

Published: January 20, 2026

The CATCH-ATTR study: CArpal Tunnel ligament amyloid-the Clue for early identification of Hereditary or wildtype systemic ATTR amyloidosis?

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: January 08, 2026